We found germline pathogenic mutations in ATM and TP53 genes and a variant of unknown significance in the BRCA2 gene, which is clarified by the multiple carcinogenesis background of the patient and indicated in hereditary cancer syndromes, particularly the Li-Fraumeni Syndrome. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.